Paper II
2023 January (Supplementary) (2019 Scheme) · 100 marks · 180 min

Question

Ondansetron/Domperidone in chemotherapy induced emesis.

Q130.2 marksShort Answers

Answer

Ondansetron is the appropriate choice — chemotherapy damages the intestinal mucosa, triggering enterochromaffin cells to release serotonin, which activates vagal 5-HT3 receptors and the chemoreceptor trigger zone; a 5-HT3 antagonist directly blocks this dominant emetogenic pathway and is first-line for chemotherapy-induced nausea and vomiting. Domperidone, a D2 antagonist, targets a comparatively minor pathway for chemotherapy-induced emesis specifically, making it a less effective choice for this indication.

Other Years Asked


Revise MBBS
Preview